TrialClinical pharmacokinetics2021

Pharmacokinetic and Pharmacodynamic Properties of Cemdisiran, an RNAi Therapeutic Targeting Complement Component 5, in Healthy Subjects and Patients with Paroxysmal Nocturnal Hemoglobinuria.

Prajakta Badri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.